量子计算增强的算法揭示新型KRAS抑制剂
Quantum Computing-Enhanced Algorithm Unveils Novel Inhibitors for KRAS
AI总结:
研究提出一种结合16量子位IBM量子计算机与经典方法的量子-经典生成模型,设计并实验验证了两种新型KRAS抑制剂,首次展示了量子生成模型在药物发现中的实际潜力与可扩展性。
摘要:
发现具有治疗潜力的小分子是化学和生物学领域的一项长期挑战。研究人员日益借助新型计算技术来简化药物开发流程,以提高命中率并降低药物上市的相关成本。为此,我们引入了一种量子-经典生成模型,该模型将在16量子位IBM量子计算机上训练的量子算法计算能力与经典方法设计小分子的成熟可靠性无缝结合。我们将这种混合生成模型应用于设计新的KRAS抑制剂,这是癌症治疗中的一个关键靶点。在研究过程中,我们合成了15种有前景的分子,并对它们进行了实验测试,以评估其与靶点结合的能力。值得注意的是,在这些候选分子中,两种具有独特骨架的分子ISM061-018-2和ISM061-22脱颖而出,表现出与KRAS的有效结合。ISM061-018-2被鉴定为广谱KRAS抑制剂,对KRAS-G12D的结合亲和力为1.4 μM。同时,ISM061-22表现出特异性的突变体选择性,对KRAS G12R和Q61H突变体展现出更高的活性。据我们所知,这项工作首次展示了使用量子生成模型产生经实验证实的生物命中物,展示了量子辅助药物发现生产可行治疗药物的实际潜力。此外,我们的发现表明,分布学习的功效与使用的量子位数量相关,突显了量子计算资源的可扩展性潜力。总体而言,我们期望我们的结果能成为在药物发现中开发更高级量子生成模型的垫脚石。
英文摘要:
The discovery of small molecules with therapeutic potential is a long-standing challenge in chemistry and biology. Researchers have increasingly leveraged novel computational techniques to streamline the drug development process to increase hit rates and reduce the costs associated with bringing a drug to market. To this end, we introduce a quantum-classical generative model that seamlessly integrates the computational power of quantum algorithms trained on a 16-qubit IBM quantum computer with the established reliability of classical methods for designing small molecules. Our hybrid generative model was applied to designing new KRAS inhibitors, a crucial target in cancer therapy. We synthesized 15 promising molecules during our investigation and subjected them to experimental testing to assess their ability to engage with the target. Notably, among these candidates, two molecules, ISM061-018-2 and ISM061-22, each featuring unique scaffolds, stood out by demonstrating effective engagement with KRAS. ISM061-018-2 was identified as a broad-spectrum KRAS inhibitor, exhibiting a binding affinity to KRAS-G12D at $1.4 μM$. Concurrently, ISM061-22 exhibited specific mutant selectivity, displaying heightened activity against KRAS G12R and Q61H mutants. To our knowledge, this work shows for the first time the use of a quantum-generative model to yield experimentally confirmed biological hits, showcasing the practical potential of quantum-assisted drug discovery to produce viable therapeutics. Moreover, our findings reveal that the efficacy of distribution learning correlates with the number of qubits utilized, underlining the scalability potential of quantum computing resources. Overall, we anticipate our results to be a stepping stone towards developing more advanced quantum generative models in drug discovery.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。